|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong YF, Cheung TH, Lo KW, Yim SF, Siu NS,
Chan SC, Ho TW, Wong KW, Yu MY, Wang VW, et al: Identification of
molecular markers and signaling pathway in endometrial cancer in
Hong KongChinese women by genome-wide gene expression profiling.
Oncogene. 26:1971–1982. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen
X and Lü B: The association between metabolic abnormality and
endometrial cancer: A large case-control study inChina. Gynecol
Oncol. 117:41–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morrow CP, Bundy BN, Kurman RJ, Creasman
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: A Gynecologic oncology Group
study. Gynecol Oncol. 40:55–65. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abeler VM and Kjørstad KE: Endometrial
adenocarcinoma in Norway. A study of a total population. Cancer.
67:3093–3103. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim HS and Song YS: International
Federation of Gynecology and Obstetrics (FIGO) staging system
revised: What should be considered critically for gynecologic
cancer? J Gynecol Oncol. 20:135–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
ASTEC study group, ; Kitchener H, Swart
AM, Qian Q, Amos C and Parmar MK: Efficacy of systematic pelvic
lymphadenectomy in endometrial cancer (MRC ASTEC trial): A
randomized study. Lancet. 373:125–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Panici P Benedetti, Basile S, Maneschi F,
Lissoni A Alberto, Signorelli M, Scambia G, Angioli R, Tateo S,
Mangili G, et al: Systematic pelvic lymphadenectomy vs. No
lymphadenectomy in early-stage endometrial carcinoma: Randomized
clinical trial. J Natl Cancer Lnst. 100:1707–1716. 2008. View Article : Google Scholar
|
|
9
|
Chan JK, Cheung MK, Huh WK, Osann K,
Husain A, Teng NN and Kapp DS: Therapeutic role of lymph node
resection in endometrioid corpus cancer: A study of 12,333
patients. Cancer. 107:1823–1830. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trovik J, Wik E, Stefansson IM,
Marcickiewicz J, Tingulstad S, Staff AC and Njolstad TS: MoMaTec
Study Group, Vandenput I, Amant F, et al: Stathmin overexpression
identifies high-risk patients and lymph node metastasis in
endometrial cancer. Clin Cancer Res. 17:3368–3377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng G, Wang X, Cao X, Shen L and Zhu J:
ZEB1 expression in endometrial biopsy predicts lymph node
metastases in patient with endometrial cancer. Dis Markers.
2014:6803612014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang T, Huang L and Zhang S: Preoperative
serum CA125: A useful marker for surgical management of endometrial
cancer. BMC Cancer. 15:3962015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bansal N, Yendluri V and Wenham RM: The
molecular biology of endometrial cancers and the implications for
pathogenesis, classification, and targeted therapies. Cancer
Control. 16:8–13. 2009.PubMed/NCBI
|
|
14
|
Zhang B, Wang Q and Pan X: MicroRNAs and
their regulatory roles inanimals and plants. J Cell Physiol.
210:279–289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Go H, Jang JY, Kim PJ, Kim YG, Nam SJ,
Paik JH, Kim TM, Heo DS, Kim CW and Jeon YK: MicroRNA-21 plays an
oncogenic role by targeting FOXO1 and activating the PI3K/AKT
pathway in diffuse large B-cell lymphoma. Oncotarget.
6:15035–15049. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, VandenBoom TG II, Kong D, Wang Z,
Ali S, Philip PA and Sarkar FH: Up-regulation of miR-200 and let-7
by natural agents leads to the reversal of
epithelial-to-mesenchymal transition in gemcitabine-resistant
pancreatic cancer cells. Cancer Res. 69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
microRNA-503 inhibits gastric cancer cell growth and
epithelial-to-mesenchymal transition. Oncol Lett. 7:1233–1238.
2014.PubMed/NCBI
|
|
19
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee TS, Jeon HW, Kim YB, Kim YA, Kim MA
and Kang SB: Aberrant microRNA expression in endometrial carcinoma
using formalin-fixed paraffin-embedded (FFPE) tissues. PLoS One.
8:e814212013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: miR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gandellini P, Folini M, Longoni N, Pennati
M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta
P, et al: miR-205 Exerts tumor-suppressive functions in human
prostate through down-regulation of protein kinase Cepsilon. Cancer
Res. 69:2287–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boren T, Xiong Y, Hakam A, Wenham R, Apte
S, Wei Z, Kamath S, Chen DT, Dressman H and Lancaster JM: MicroRNAs
and their target messenger RNAs associated with endometrial
carcinogenesis. Gynecol Oncol. 110:206–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hiroki E, Akahira J, Suzuki F, Nagase S,
Ito K, Suzuki T, Sasano H and Yaegashi N: Changes in microRNA
expression levels correlate with clinicopathological features and
prognoses in endometrial serous adenocarcinomas. Cancer Sci.
101:241–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Campbell K, Nuss RC and Benrubi GI: An
evaluation of the clinical staging of endometrial cancer. J Reprod
Med. 33:8–10. 1988.PubMed/NCBI
|
|
28
|
Creasman WT, Morrow CP, Bundy BN, Homesley
HD, Graham JE and Heller PB: Surgical pathologic spread patterns of
endometrial cancer. A gynecologic oncology group study. Cancer.
60:(8 Suppl). 2035–2041. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karaayvaz M, Zhang C, Liang S, Shroyer KR
and Ju J: Prognostic significance of miR-205 in endometrial cancer.
PLoS One. 7:e351582012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Todo Y, Kato H, Kaneuchi M, Watari H,
Takeda M and Sakuragi N: Survival effect of para-aortic
lymphadenectomy in endometrial cancer (SEPAL study): A
retrospective cohort analysis. Lancet. 375:1165–1172. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitamura T, Watari H, Todo Y, Kato T,
Konno Y, Hosaka M and Sakuragi N: Lymphadenectomy can be omitted
for low-risk endometrial cancer based on preoperative assessments.
J Gynecol Oncol. 25:301–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trovik J, Wik E, Werner HM, Krakstad C,
Helland H, Vandenput I, Njolstad TS, Stefansson IM, Marcickiewicz
J, Tingulstad S, et al: Hormone receptor loss in endometrial
carcinoma curettage predicts lymph node metastasis and poor outcome
in prospective multicentre trial. Eur J Cancer. 49:3431–3441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dinkelspiel HE, Wright JD, Lewin SN and
Herzog TJ: Contemporary clinical management of endometrial cancer.
Obstet Gynecol Int. 2013:5838912013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Todo Y, Sakuragi N, Nishida R, Yamada T,
Ebina Y, Yamamoto R and Fujimoto S: Combined use of magnetic
resonance imaging, CA 125 assay, histologic type, and histologic
grade in the prediction of lymph node metastasis in endometrial
carcinoma. Am J Obstet Gynecol. 188:1265–1272. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Todo Y, Okamoto K, Hayashi M, Minobe S,
Nomura E, Hareyama H, Takeda M, Ebina Y, Watari H and Sakuragi N: A
validation study of a scoring system to estimate the risk of lymph
node metastasis for patients with endometrial cancer for tailoring
the indication of lymphadenectomy. Gynecol Oncol. 104:623–628.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chung TK, Cheung TH, Huen NY, Wong KW, Lo
KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, et al: Dysregulated
microRNAs and their predicted targets associated with endometrioid
endometrial adenocarcinoma in Hong Kong women. Int J Cancer.
124:1358–1365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Torres A, Torres K, Pesci A, Ceccaroni M,
Paszkowski T, Cassandrini P, Zamboni G and Maciejewski R:
Diagnostic and prognostic significance of miRNA signatures in
tissues and plasma of endometrioid endometrial carcinoma patients.
Int J Cancer. 132:1633–1645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Berber U, Yilmaz I, Narli G, Haholu A,
Kucukodaci Z and Demirel D: miR-205 and miR-200c: Predictive micro
RNAs for lymph node metastasis in triple negative breast cancer. J
Breast Cancer. 17:143–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Abu-Rustum NR, Gomez JD, Alektiar KM,
Soslow RA, Hensley ML, Leitao MM Jr, Gardner GJ, Sonoda Y, Chi DS
and Barakat RR: The incidence of isolated paraaortic nodal
metastasis in surgically staged endometrial cancer patients with
negative pelvic lymph nodes. Gynecol Oncol. 115:236–238. 2009.
View Article : Google Scholar : PubMed/NCBI
|
